>Go!
NEWS SEARCH

06.08.2009 | Investors

Watson to Present at Upcoming Investor Conferences

Goldman Sachs 30th Annual Healthcare Conference; 8th Annual Needham Life Sciences Conference

CORONA, CA, Jun 08, 2009 (MARKETWIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 9:40 a.m. Eastern Daylight Time. Mr. Bisaro will also present at the 8th Annual Needham Life Sciences Conference on Thursday, June 11, 2009 at 2:00 p.m. Eastern Daylight Time.

Both presentations will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com.

The webcast for Goldman can also be accessed at the following URL:

http://cc.talkpoint.com/gold006/060909a_mg/?entity=37_C1RTQKG

The webcast for Needham can also be accessed at the following URL:

http://www.wsw.com/webcast/needham31/wpi/

An archived version will be available for 30 days after the live presentations and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

CONTACT:
Watson Pharmaceuticals, Inc.
Patty Eisenhaur
(951) 493-5611

SOURCE: Watson Pharmaceuticals





                    
Media Contacts
Amy Rose
Global Corporate Media Relations
+1 (862) 289 3072
Lisa Brown
Global Corporate Media Relations
+1 (862) 261 7320
Fran DeSena
U.S. Product Media Relations
+1 (862) 261 8820
Mark Marmur
International Communications & Public Relations
+44 7725 758677

For local media contacts in other countries, please visit the relevant country website.

Investor relations:

Karina Calzadilla
Investor Relations
+1 (862) 261 7488